Navigation Links
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2014 And To Provide A Business Update
Date:8/7/2014

ADDISON, Texas, Aug. 7, 2014 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the second quarter ending June 30, 2014 financial results and to provide a business update on August, 15, 2014 at 9:00 a.m. Eastern Time.

To participate in the conference call please dial (877) 387-2201, for international callers dial (850) 429-1388 (access code 24097#) five to ten minutes prior to the initiation of the teleconference.  If you are unable to listen to the live broadcast, a replay of the call will be available starting on August 15, 2014 two hours following the end of the call until August 29, 2014 at 11:59 p.m. Eastern Time.  For the U.S. replay, please dial (866) 415-9493 and international callers please dial (205) 289-3247 (access code 24097#).  You may also access the replay of the call two hours following the end of the call until August 29, 2014 at 11:59 p.m. Eastern Time via the web by logging onto http://replay.multipointcom.com.

About ULURU Inc.:ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers with improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system. For more information about ULURU Inc., please visit www.uluruinc.com.  For more information about Altrazeal®, please visit www.Altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and other reports filed by us with the Securities and Exchange Commission.Contact: Investor RelationsContact: CompanyJim MacDonald Kerry P. Gray Torrey Hills CapitalPresident & CEO (858) 456-7300 Terry K. Wallberg Vice President & CFO(214) 905-5145 

 

 


'/>"/>
SOURCE ULURU Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ULURU Inc. Announces the Expansion of the International Marketing Network
2. ULURU Inc. Reports Third Quarter 2013 Financial Results
3. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2013
4. ULURU Inc. Completes Redemption Of Preferred Stock
5. ULURU Inc. Reports Second Quarter 2013 Financial Results
6. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2013
7. ULURU Inc. Reports First Quarter 2013 Financial Results
8. ULURU Inc. Announces Conference Call To Discuss Financial Results For The First Quarter Ended March 31, 2013
9. ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2012
10. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2012 and to Provide a Business Update
11. ULURU Inc. Business Update And Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... -- It should come as no surprise to anyone that ... midst of a crippling opioid epidemic. According to the ... overdose deaths from opiate-based medications has quadrupled, Says, Dr. ... from 2001 to 2015". During this time, the prescription rate ... drawing a compelling link between prescription and eventual addiction. The ...
(Date:7/12/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... to resolve pending patent litigation in the U.S. District Court ... regarding the Cialis ® (tadalafil) unit dose patent. This ... As part of the agreement, Cialis exclusivity is now expected ... "The unit dose patent for Cialis is valid and ...
(Date:7/11/2017)... July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing ... patients who suffer from painful intercourse and other painful pelvic pain conditions ... due to menopause. ... VuVatech LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a ...
Breaking Medicine Technology:
(Date:7/24/2017)... Kansas City, MO (PRWEB) , ... July 24, 2017 , ... ... for the acclaimed Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI), part of ... an interim basis since 2016. , Cheerag D. Upadhyaya, MD. M.Sc., FAANS joins ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... 24, 2017 , ... Peruvian Ayahuasca retreat, East West Lodge, ... to and divided between two full-time university students enrolled in U.S. or Canadian ... To apply for the scholarship, students are asked to submit an essay between ...
(Date:7/24/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... to expand its solution to help government contractors more quickly and cost-effectively comply with ... address the authentication requirements within NIST SP800-171, but no matter how you address ...
(Date:7/24/2017)... ... ... that, although people are taking more steps to protect themselves from sunburn, half of all ... sunburn within the past year. It’s common and people have been dealing with them since ... people become conscientious of the risks that accompany sunburns. , The team at AloeVera.com ...
Breaking Medicine News(10 mins):